ES8601687A1 - Procedimiento para producir una tableta de administracion oral de liberacion controlada, independiente del ph - Google Patents

Procedimiento para producir una tableta de administracion oral de liberacion controlada, independiente del ph

Info

Publication number
ES8601687A1
ES8601687A1 ES531346A ES531346A ES8601687A1 ES 8601687 A1 ES8601687 A1 ES 8601687A1 ES 531346 A ES531346 A ES 531346A ES 531346 A ES531346 A ES 531346A ES 8601687 A1 ES8601687 A1 ES 8601687A1
Authority
ES
Spain
Prior art keywords
dipyridamole
acid
tablets
independent controlled
controlled releasable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES531346A
Other languages
English (en)
Other versions
ES531346A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BOEHRINGER INGELHEIM Ltd
Boehringer Ingelheim Corp
Original Assignee
BOEHRINGER INGELHEIM Ltd
Boehringer Ingelheim Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BOEHRINGER INGELHEIM Ltd, Boehringer Ingelheim Corp filed Critical BOEHRINGER INGELHEIM Ltd
Publication of ES8601687A1 publication Critical patent/ES8601687A1/es
Publication of ES531346A0 publication Critical patent/ES531346A0/es
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Materials For Medical Uses (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

PROCEDIMIENTO PARA PRODUCIR UNA TABLETA DE ADMINISTRACION DE LIBERACION CONTROLADA, INDEPENDIENTE DEL PH. SE MEZCLAN INTIMAMENTE ENTRE SI DIPIRIDAMOL O UNA DE SUS SALES DE ADICION DE ACIDO, AL MENOS 18 EQUIVALENTES DE ACIDO DE AL MENOS UN ACIDO O UNA SUSTANCIA ACIDA FARMACEUTICAMENTE ACEPTABLE, NO TOXICOS, POR MOL DE DIPIRIDAMOL Y UNA CANTIDAD SUFICIENTE DE UN AGENTE DE DISGREGACION, ASI COMO UN EXCIPIENTE CONVENCIONAL Y LA MEZCLA RESULTANTE SE GRANULA EVENTUALMENTE CON GRASAS DISAUELTAS EN DISOLVENTES ORGANICOS O CON BARNICES RESISTENTES A LOS JUGOS GASTRICOS, Y A CONTINUACION SE COMRPIME PARA FORMAR TABLETAS.
ES531346A 1983-04-08 1984-04-06 Procedimiento para producir una tableta de administracion oral de liberacion controlada, independiente del ph Granted ES531346A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US48328583A 1983-04-08 1983-04-08

Publications (2)

Publication Number Publication Date
ES8601687A1 true ES8601687A1 (es) 1985-11-01
ES531346A0 ES531346A0 (es) 1985-11-01

Family

ID=23919470

Family Applications (1)

Application Number Title Priority Date Filing Date
ES531346A Granted ES531346A0 (es) 1983-04-08 1984-04-06 Procedimiento para producir una tableta de administracion oral de liberacion controlada, independiente del ph

Country Status (20)

Country Link
EP (1) EP0121901B1 (es)
JP (1) JPS6034906A (es)
KR (1) KR880002139B1 (es)
AT (1) ATE32980T1 (es)
AU (1) AU570446B2 (es)
CA (1) CA1219216A (es)
DD (1) DD222496A5 (es)
DE (1) DE3469848D1 (es)
DK (1) DK166259C (es)
ES (1) ES531346A0 (es)
FI (1) FI82604C (es)
GR (1) GR81907B (es)
HU (1) HU191542B (es)
IE (1) IE57220B1 (es)
IL (1) IL71458A (es)
NO (1) NO164958C (es)
NZ (1) NZ207768A (es)
PH (1) PH21585A (es)
PT (1) PT78380B (es)
ZA (1) ZA842562B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5188840A (en) * 1985-09-26 1993-02-23 Chugai Seiyaku Kabushiki Kaisha Slow-release pharmaceutical agent
JPH0776172B2 (ja) * 1986-04-16 1995-08-16 藤沢薬品工業株式会社 マトリツクス錠
JP2535141B2 (ja) * 1995-01-17 1996-09-18 中外製薬株式会社 フマル酸含有徐放性製剤
DE10337697A1 (de) * 2003-08-16 2005-03-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tablette enthaltend 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)-phenyl-amino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester oder dessen Salze
BG860Y1 (bg) * 2004-09-17 2007-02-28 "Софарма" Ад Лекарствена форма на дипиридамол
KR20080037732A (ko) * 2005-08-22 2008-04-30 노파르티스 아게 ｐＨ-의존성 약물, ｐＨ 개질제 및 지연제를 포함하는제약학적 조성물
EP2101733B1 (en) 2006-12-13 2012-09-26 F. Hoffmann-La Roche AG Powder formulation for valganciclovir

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2336218C3 (de) * 1973-07-17 1985-11-14 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Orale Arzneiform
DD146547A5 (de) * 1978-07-15 1981-02-18 Boehringer Sohn Ingelheim Arzneimittel-retardform mit unloeslichen poroesen diffusionshuellen
DE3000979A1 (de) * 1980-01-12 1981-07-23 Dr. Karl Thomae Gmbh, 7950 Biberach Neue dipyridamol-retardformen und verfahren zu ihrer herstellung
DE3124090A1 (de) * 1981-06-19 1983-01-05 Dr. Karl Thomae Gmbh, 7950 Biberach Neue orale dipyridamolformen
JPS5839618A (ja) * 1981-09-04 1983-03-08 Chugai Pharmaceut Co Ltd 持続性積層錠剤

Also Published As

Publication number Publication date
NO164958B (no) 1990-08-27
KR880002139B1 (ko) 1988-10-17
FI82604B (fi) 1990-12-31
JPH0521892B2 (es) 1993-03-25
AU570446B2 (en) 1988-03-17
IL71458A (en) 1987-09-16
HU191542B (en) 1987-03-30
FI82604C (fi) 1991-04-10
NO841372L (no) 1984-10-09
NZ207768A (en) 1987-02-20
IE57220B1 (en) 1992-06-03
EP0121901A1 (en) 1984-10-17
DK166259C (da) 1993-08-23
DK181084D0 (da) 1984-04-06
DK181084A (da) 1984-10-09
DD222496A5 (de) 1985-05-22
JPS6034906A (ja) 1985-02-22
DE3469848D1 (en) 1988-04-21
ATE32980T1 (de) 1988-04-15
KR840008588A (ko) 1984-12-17
FI841369A0 (fi) 1984-04-06
GR81907B (es) 1984-12-12
IE840856L (en) 1984-10-08
PT78380B (en) 1986-08-14
ZA842562B (en) 1985-12-24
ES531346A0 (es) 1985-11-01
IL71458A0 (en) 1984-07-31
EP0121901B1 (en) 1988-03-16
CA1219216A (en) 1987-03-17
DK166259B (da) 1993-03-29
HUT34345A (en) 1985-03-28
AU2660984A (en) 1984-10-11
FI841369A (fi) 1984-10-09
PH21585A (en) 1987-12-11
PT78380A (en) 1984-05-01
NO164958C (no) 1990-12-05

Similar Documents

Publication Publication Date Title
MA23170A1 (fr) Procede de preparation d'un nouveau compose .
NZ510384A (en) Sustained release ranolazine formulations
IL71506A0 (en) Rapid dissolving,uniform pharmaceutical compositions of low water solubility drugs and their preparation
ZA894128B (en) Use of gamma-hydroxybutryic acid salts for preparing pharmaceutical compositions for use in the treatment of alcoholism,and the compositions obtained
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
JPS57159772A (en) 3,4-dihydro-5h-2,3-benzodiazepine derivatives, acid addition salts, manufacture and medicinal composition containing them
MTP943B (en) Resenate of a substituted carboxyde acid,the preparation and use thereof,and pharmaceutical compositions containing it
EP0257786A3 (en) Dosage form for delivering acid sensitive beneficial agent
IL73125A0 (en) 1-benzyl-aminoalkyl-pyrrolidinones and acid addition salts thereof,their preparation and pharmaceutical compositions containing them
IL83032A (en) Pharmaceutical compositions containing calcium salts and their preparation
GR3001185T3 (en) Stable solid pharmaceutical composition containing ibuprofen and codeine
JPS57144219A (en) Azobissalicylic acid and salts thereof and medicinal composition containing them
GB2064514B (en) Flavan compounds and acid addition salts thereof and pharmaceutical compositions thereof
JPS56154417A (en) Use of 3,3'-azobis -(6-hydroxybenzoic acid) as drug and pharmaceutical composition containing it
ES8601687A1 (es) Procedimiento para producir una tableta de administracion oral de liberacion controlada, independiente del ph
IL71988A (en) 8beta-(1-pyrazolyl)methylergoline derivatives and acid addition salts thereof,their preparation and pharmaceutical compositions containing them
IL73776A0 (en) Tetrazole derivatives,their preparation and pharmaceutical compositions containing them
GB1475861A (en) Pharmaceutical composition
NZ225791A (en) Substituted tetrazole derivatives and pharmaceutical compositions
IL93590A0 (en) Acid addition salts of naphthalenmethanamino and pharmaceutical compositions containing them
JPS562977A (en) *33alkylaminoo22hydroxypropoxy**furann22 carboxylic acid anilide and its addition salt* its manufacture and medicinal composition containing it
IL74616A0 (en) Substituted isochromanes and benzoxepines,and acid addition salts thereof,their preparation and pharmaceutical compositions containing them
IL85856A0 (en) Tert.-butylamino-3-(phenyl-2'-phenoxy)-1-propanol-2,its acid addition salts and pharmaceutical compositions containing them
CA2161683A1 (en) Veterinary composition containing a proton pump inhibitor